The Margolis Lab studies the effects of neurotransmitters and inflammation on enteric nervous system development and function. The goal of Dr. Margolis’s research is to understand the enteric nervous system (ENS) and disorders that have in common an effect both on the brain and the gut, sometimes referred to as the “brain-gut axis.” She has published novel observations on the roles that enteric neurotransmitters (specifically serotonin and oxytocin) play in ENS development and how signaling from such neurotransmitters may, when abnormal, result in gastrointestinal (GI) disorders such as inflammatory bowel disease (e.g., Crohn’s disease and ulcerative colitis), motility dysfunction (e.g., chronic constipation or irritable bowel syndrome), and necrotizing enterocolitis (a devastating intestinal inflammatory disorder primarily of preterm infants). This research has recently provided important insights into how abnormalities of the ENS can arise in children with brain-gut axis disorders such as autism, antenatal antidepressant exposure, and irritable bowel syndrome. Dr. Margolis’s research is funded by the National Institutes of Health, the Department of Defense, and private donations.
For questions or inquiries regarding opportunities in the Margolis Lab please contact: Kara Gross Margolis email@example.com